Business
Cresco Labs Establishes At-the-Market Offering
CHICAGO, January 30, 2026--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the "Equity Distribution Agreement") with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 m
About this update from Cresco Labs, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":421,"url":"https://media.zenfs.com/en/business-wire.com/8da2524c36b6011b9576f277685835a4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GFYnOzGYADEjlsvSwGrbqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTg0MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8da2524c36b6011b9576f277685835a4","width":480,"height":421}},"lazy":false},{"type":"text","content":"NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES","length":92,"tagName":"p","attribs":{}},{"type":"text","content":"CHICAGO, January 30, 2026--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it has entered into an equity distribution agreement (the "Equity Distribution Agreement") with Haywood Securities Inc. pursuant to which the Company may, from time to time, sell up to approximately US$100 million (C$140 million) of subordinate voting shares ("Subordinate Voting Shares") in the capital of the Company (the "ATM Program"). The Company intends to use the net proceeds of the ATM Program, if any, principally for general corporate purposes, including potential future acquisitions.","length":841,"tagName":"p"},{"type":"text","content":""Establishing this ATM program provides us with another flexible tool to support our strategic objectives as the industry continues to mature and federal reform progresses. Consistent with our approach, we remain focused on disciplined capital allocation and driving long-term, risk-adjusted value for our shareholders. Use of the program would be considered opportunistically, with a focus on market conditions, our equity valuation, and the ability to deploy capital into accretive opportunities that enhance profitability and strengthen our balance sheet," said Charlie Bachtell, CEO of Cresco Labs.","length":612,"tagName":"p"},{"type":"text","content":"Since the Subordinate Voting Shares will be distributed at trading prices prevailing at the time of the sale, prices may vary between purch...